u/plain_titration

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

read the combination arms separately from the monotherapy arms

The first thing I noticed was a jacket doing up. The scale had been flat for three weeks at that point.

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

week two with nothing happening is normal

DEXA has a real error margin and people quote it to one decimal

Asked for the policy bulletin by number and wrote the appeal against its criteria line by line. Approved on the second level after a flat first-level denial.

step therapy is a documentation problem, not an argument

pens and vials are the same molecule with different logistics

step therapy is a documentation problem, not an argument

A1c, CGM, or fingersticks — which are we discussing?

Yes. The central component is the one that explains the reports on this site better than gastric emptying does.

Kept the same programme for a year instead of changing it every six weeks. That was the change that worked.

document what has been tried and for how long, that is the whole case

What does the wiki page on this say — genuinely asking, not deflecting?

a mechanism you can state is not a mechanism you have demonstrated

2.4 is a ceiling, not a target

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

This. Waist measurement kept moving through my longest stall and it was the only thing that kept me sane.

Appeal deadlines run from the date on the determination letter.

Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.

Postprandial excursions typically respond earlier than fasting glucose, so the sequence people observe is not a sign that something is not working.

Disagreeing with this line: that endpoint is from the obesity programme and does not answer the question.

Careful — you have a plausible mechanism and no evidence that it is the operative one in the case you are describing.

Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.

text only here, by community rule, and it works better than you would think

How long was the stall before you decided it was a stall?

Disagree with this specific line. A pause at 0.5mg is not evidence that 0.5mg has stopped working.

What has been documented as tried, and for how long?

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

the second-level appeal is where things actually turn

What is the appeal deadline on the letter?

metformin and an incretin agonist are not in competition

week 14 plateau is the most predictable thing in this entire board

the ladder exists because the gut needs the time, not because the pharmacy likes paperwork

This. Albumin binding and modification are why the half-life is what it is, and it is a design decision rather than an accident.

long-acting amylin is the whole point of the molecule

Are you measuring anything other than weight? Waist is usually the one that keeps moving.

Prior authorisation criteria are republished each plan year.

Disagreeing with this line: the deadline runs from the letter date and treating it otherwise is expensive.

Yes. The starting dose is a tolerance step. It is not supposed to do very much.

grip strength and lift numbers are cheap longitudinal markers

Fasted and hydrated the same way for both scans?

no question is too basic here, that is the entire point of the board